(A) Statistical analysis of invasion in human cervical cancer C33A cells treated with miR-4454 mimics, miR-4454 mimics with sh-ABHD2/NUDT21, miR-4454 inhibitors, and miR-4454 inhibitors with sh-ABHD2/NUDT21. (B) Statistical analysis of invasion in human cervical cancer CaSki cells treated with miR-4454 mimics, miR-4454 mimics with sh-ABHD2/NUDT21, miR-4454 inhibitors, and miR-4454 inhibitors with sh-ABHD2/NUDT21. (C) Transwell assay was used to detect cell invasion in C33A and CaSki cells. (D) Statistical analysis of migration in human cervical cancer C33A cells treated with miR-4454 mimics, miR-4454 mimics with sh-ABHD2/NUDT21, miR-4454 inhibitors, and miR-4454 inhibitors with sh-ABHD2/NUDT21. (E) Statistical analysis of migration in human cervical cancer CaSki cells treated with miR-4454 mimics, miR-4454 mimics with sh-ABHD2/NUDT21, miR-4454 inhibitors, and miR-4454 inhibitors with sh-ABHD2/NUDT21. (F) Transwell assay was used to detect cell migration in C33A and CaSki cells.